Investment Banking, Offering Practices, and Research Independence
Underwriting and research conflicts
Investment banking supervision sits where Rule 5110 (Corporate Financing), Regulation M, and Rule 2241 (research conflicts) meet. Under Rule 5110, offering documents and underwriting terms must be filed with FINRA Corporate Financing before the offering - commonly at least 15 business days before the effective date, with shorter windows for shelf takedowns - and underwriting compensation must be fair and reasonable. Watch for unfair terms: excessive non-accountable expense allowances, unusually broad rights of first refusal, and undisclosed compensation.
Allocation rules: Rule 5130 restricts IPO allocations to accounts in which restricted persons (industry personnel, immediate family, finders) hold a beneficial interest; Rule 5131 prohibits spinning - allocating hot IPO shares to executives in exchange for banking business - and restricts flipping and quid pro quo allocations. Rule 105 prohibits purchasing offering shares if the account sold short during the five business days before pricing.
Research: analysts may not be supervised by investment banking personnel or have compensation reviewed by them, may not be promised favorable coverage, and must be separated from banking by information barriers. Quiet periods bar the managing underwriter from publishing research for 40 days after an IPO and other syndicate members for 25 days (10 and 3 days after a secondary offering). Regulation M restricts stabilizing bids, syndicate covering transactions, and penalty bids.
Rule of thumb: whenever a question pairs research with investment banking, the answer is 'no banking influence over the analyst.' Worked example: a banker asks the analyst to publish an initiating report five days after the IPO the firm managed. That violates the 40-day quiet period; the analyst must refuse, and the Series 24 principal must not apply pressure.